Advanced search
Publication Cover
Current Medical Research and Opinion Volume 23, 2007 - Issue 9
Submit an article Journal homepage
129
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Effectiveness and duration of daptomycin therapy in resolving clinical symptoms in the treatment of complicated skin and skin structure infections

Jake E. Krige University of Cape Town Health Sciences Faculty, Cape Town, South Africa
,
Kimberly Lindfield Cubist Pharmaceuticals, Lexington, MA, USA
,
Lawrence Friedrich Cubist Pharmaceuticals, Lexington, MA, USACorrespondence[email protected]
,
Constance Otradovec Cubist Pharmaceuticals, Lexington, MA, USA
,
William J. Martone Cubist Pharmaceuticals, Lexington, MA, USA
,
David E. Katz Cubist Pharmaceuticals, Lexington, MA, USA
&
Frank Tally Cubist Pharmaceuticals, Lexington, MA, USA
 show all
Pages 2147-2156 | Accepted 06 Jul 2007, Published online: 31 Jul 2007

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Mazen S. Bader & Annie Brooks. (2012) Medical Management of Diabetic Foot Infections. Postgraduate Medicine 124:2, pages 102-113.
Read now
Beth White & R Andrew Seaton. (2011) Complicated skin and soft tissue infections: literature review of evidence for and experience with daptomycin. Infection and Drug Resistance 4, pages 115-127.
Read now
A. Gonzalez-Ruiz & J. Richardson. (2008) Are Glycopeptides Still Appropriate and Convenient for Empiric Use?. Journal of Chemotherapy 20:5, pages 531-541.
Read now
Paul B Cornia, Heather L Davidson & Benjamin A Lipsky. (2008) The evaluation and treatment of complicated skin and skin structure infections. Expert Opinion on Pharmacotherapy 9:5, pages 717-730.
Read now

Articles from other publishers (13)

John BradleyChad GlasserHernando PatinoSandra R. ArnoldAntonio ArrietaBlaise CongeniRobert S. Daum, Tsoline Kojaoghlanian, Minjung YoonDiane AnastasiouDominik J. WolfPaula Bokesch. (2017) Daptomycin for Complicated Skin Infections: A Randomized Trial. Pediatrics 139:3.
Crossref
W. He, Y. Zhang, H. Chen, C. Zhao & H. Wang. (2014) Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials. Journal of Antimicrobial Chemotherapy 69:12, pages 3181-3189.
Crossref
Steven Y. C. Tong, Luke F. Chen & Vance G. FowlerJrJr. (2011) Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?. Seminars in Immunopathology 34:2, pages 185-200.
Crossref
José Barberán & M. Carmen Fariñas. (2012) Tratamiento con daptomicina en las infecciones complicadas de piel y partes blandas. Enfermedades Infecciosas y Microbiología Clínica 30, pages 33-37.
Crossref
A. Sotto, D. Laouini, N. Bouziges, N. Jourdan, J.-L. Richard & J.-P. Lavigne. (2010) Activité in vitro de la daptomycine vis-à-vis de souches cliniques isolées de plaies du pied chez des diabétiques. Pathologie Biologie 58:1, pages 73-77.
Crossref
loannis A Bliziotis, Eleni Plessa, George Peppas & Matthew E Falagas. (2010) Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis. Annals of Pharmacotherapy 44:1, pages 97-106.
Crossref
MH Wilke. (2010) Multiresistant bacteria and current therapy - the economical side of the story. European Journal of Medical Research 15:12, pages 571.
Crossref
Richard H. Baltz. 2009. Natural Product Chemistry for Drug Discovery. Natural Product Chemistry for Drug Discovery 395 409 .
Kent B. Crossley & Joseph John. 2009. Staphylococci in Human Disease. Staphylococci in Human Disease 570 593 .
Carlos Pigrau & Benito Almirante. (2009) Oxazolidinonas, glucopéptidos y lipopéptidos cíclicos. Enfermedades Infecciosas y Microbiología Clínica 27:4, pages 236-246.
Crossref
P. E. Pertel, B. I. Eisenstein, A. S. Link, B. Donfrid, E. J. A. Biermann, P. Bernardo & W. J. Martone. (2009) The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas. International Journal of Clinical Practice 63:3, pages 368-375.
Crossref
R. A. Seaton. (2008) Daptomycin: rationale and role in the management of skin and soft tissue infections. Journal of Antimicrobial Chemotherapy 62:Supplement 3, pages iii15-iii23.
Crossref
D. E. Katz, K. C. Lindfield, J. N. Steenbergen, D. P. Benziger, K. J. Blackerby, A. G. Knapp & W. J. Martone. (2008) A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria. International Journal of Clinical Practice 62:9, pages 1455-1464.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.